COVID-19 Vaccine Passes First Human Trial, Declared Safe For Use

Phase1 human trial of a COVID-19 vaccine called the Ad5-nCoV shows that it is safe, well-tolerated and able to generate an immune response against the SARS-CoV-2 in participants. The trial demonstrates that a single dose of the new vaccine produces virus-specific antibodies and T cells in 14 days, making it a potential candidate for further investigation.

The World Health Organisation (WHO)has said the African Region is on the verge of being certified wild poliovirus free, the Regional Director for Africa, Matshidiso Moeti disclosed. According to PremiumTimes, Moeti made the disclosure on Tuesday during the virtual World Health Assembly 2020 in Geneva, adding that the certification will be a major public health milestone in Africa.

Hydroxychloroquine Not Safe For COVID-19 Patients - WHO

A clinical trial of hydroxychloroquine as a means of treatment for COVID-19 has been temporarily suspended by the World Health Organization, WHO. The move by WHO followed new data suggesting that the drugs increase mortality among patients.

More Articles ...